EMCDDA Home
  • EN
Search

Table GPS-3. Last year prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population

Country Geographical areaYearReferenceAge range all adultsSample size all adultsCannabis (%)Cocaine (%) (1)Amphetamines (%) (2)Ecstasy (%) (3)LSD (%)
Belgium
Vlaanderen (Brussels excluded)1994(1)18–6522591.50.20.30.1:
French Community1996–97(2)18–49978:::::
French Community1998–99(3)18–491006:::::
French Community2000(4)18–49693:::::
National2001(5)15–647347:::::
National2004(6)15–64:5.0::::
Bulgaria
National2005(1)18–6010361.50.30.40.50.2
National2007(2)15–6460271.90.50.40.60.1
Czech Republic
National2002(1)18–64252610.9:1.12.51.0
National2004(2)18–6435269.30.20.73.50.4
Denmark
National1990(1)>=1620005.00.20.7::
National1994(2):::::::
National2000(3)16–64118256.20.81.30.50.2
National2005(4)16–64133105.21.00.70.30.1
National2008(5)16–6434085.51.41.20.40.1
Germany
East Germany1990(1):::::::
Western Germany1990(2):::::::
Old and new Länder1995(3)18–5978334.40.80.70.8:
Old and new Länder1997(4)18–5980194.00.60.40.8:
National2000(5)18–5981396.00.90.60.70.2
National2003(6)18–5980616.91.00.90.80.3
National2006(7)18–6479124.70.60.50.40.1
Estonia
National1998(1)18–6423172.0:1.0::
National2003(2)15–64:4.60.61.31.70.3
Ireland
National1998(1)18–64826:::::
National1998(2)18–64:9.41.32.62.41.4
National2000(3)18–64907:::::
National2002–03(4)15–6449185.01.10.41.10.1
National2006–07(5)15–6449676.31.70.41.20.2
Greece
Athens1993(1)12–6421032.50.20.1::
National (except Aegean and Ionian Islands)1998(2)15–6433984.40.50.00.1:
National (except Aegean and Ionian Islands)2004(3)15–6443511.70.10.00.20.1
Spain
National1995(1)15–6488887.31.91.11.3:
National1997(2)15–65125157.61.70.90.9:
National1999(3)15–64122347.01.60.70.8:
National2001(4)15–64141139.72.61.21.9:
National2003(5)15–641203311.32.70.81.4:
National2005–06(6)15–642793411.23.00.71.2:
National2007-08(7)15–642371510.13.10.91.2:
France
National1992(1)15–6420993.90.3:::
Metropolitan France1995(2)18–7517874.70.20.3::
National1999(3)18–6917427.40.20.10.20.1
National2000(4)15–64113178.40.20.20.20.2
Metropolitan France2002(5)15–6417449.80.30.00.30.1
National2005(6)15–64258798.60.60.10.40.1
Italy
National2001(1)15–4460326.21.10.10.20.0
National2003(2)15–54118697.11.20.20.40.2
National2005(3)15–642799511.22.20.40.50.6
National2007(4)15–64728914.62.20.40.6:
Cyprus
National2006(1)15–6435042.10.60.31.00.5
Latvia
National2003(1)15–6445343.80.21.10.80.5
National2007(2)15–6445004.90.50.91.50.2
Lithuania
National2004(1)15–6442072.20.30.30.40.1
Luxembourg
National1998(1)15–64:4.00.2:0.0:
Hungary
National2001(1)18–6523592.40.20.70.80.7
National2003(2)18–5436753.90.41.01.40.5
National2007(3)18–6427102.30.20.50.50.2
Malta
National2001(1)18–6417550.80.30.00.20.1
Netherlands
National(4)1997–98(1)15–64175905.50.70.40.8:
National(4)2001(2)15–6423125.50.70.41.10.0
National2005(3)15–6445165.40.60.31.20.1
Austria
National2004(1)15–6439807.50.90.80.90.2
Poland
National2002(1)16–64:2.80.50.70.20.4
National2006(2)15–6428592.70.20.70.30.1
Portugal
National2001(1)15–64141863.30.30.10.40.1
National2007(2)15–64122023.60.60.20.40.1
Romania
National2004(1)15–64::::::
National2007(2)15–6467970.40.00.00.10.0
Slovenia
::::::::::
Slovakia
National1996(1)15–64:5.30.80.5::
National1998(2)15–64:4.80.40.31.1:
National2000(3)15–6412547.20.40.41.2:
National2002(4)18–6412696.30.60.20.9:
National2004(5)15–6413155.80.50.31.6:
National2006(6)15–6413056.90.60.31.6:
Finland
National1992(1)18–7434571.2::::
National1996(2)16–7430091.9::::
National1998(3)15–6925682.50.20.20.2:
National2000(4)15–6416772.20.20.40.30.2
National2002(5)15–6423772.90.30.50.50.1
National2004(6)15–6423522.90.30.60.50.1
National2006(7)15–6428023.60.50.60.50.1
Sweden
National1994(1)16–64806:::::
National1996(2)16–641136:::::
National1998(3)16–6413590.90.10.10.0:
National2000(4)16–6417500.70.00.20.20.0
National2004(5)18–6495142.2::::
National2005(6)16–64305382.0::::
National2006(7)16–64417012.0::::
National2007(8)16–6444012.1::::
United Kingdom
England and Wales1994(1)16–5996458.40.52.41.01.3
England and Wales1996(2)16–59109359.50.63.21.71.0
England and Wales1998(3)16–59998410.31.33.01.50.8
England and Wales2000(4)16–591301810.52.02.11.80.7
England and Wales2001–02(5)16–592016510.62.01.62.20.3
England and Wales2002–03(6)16–592358610.92.11.62.00.3
England and Wales2003–04(7)16–592442210.82.51.52.00.2
England and Wales2004–05(8)16–59285099.72.01.41.80.2
England and Wales2005–06(9)16–59297488.72.41.31.60.3
England and Wales2006–07(10)16–59310548.22.61.31.80.2
England and Wales2007-08(11)16-59286887.42.31.01.50.3
Northern Ireland2002–03(13)15–6435165.40.50.81.60.1
Northern Ireland2005(14)16–59:5.81.11.01.60.2
Northern Ireland2006-07(15)16–6424396.10.90.50.90.2
Scotland2003(16)16–6435067.41.41.31.50.1
Scotland2004(17)16–6432935.81.40.91.00.2
Scotland2006(18)16–59315711.03.82.23.20.6
United Kingdom2004(19)::10.32.31.51.90.2
United Kingdom2006(20)16–59:8.42.71.41.90.2
Croatia
::::::::::
Turkey
::::::::::
Norway
National1999(1)15–6418034.50.61.20.7:
National2004(2)15–6426694.60.81.10.50.2

Notes:

 : indicates data not available 

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy. 

 (3) For Spain: ecstasy and other designer drugs. 

 (4) In the Netherlands the figures for 2001 have been recomputed using only the interviews conducted with CAPI method (Computer Assisted Personal Interview) and excluding other methods of data collection (mail, telephone, etc.) to ensure comparability with 1997 and 2005. For 2005, only respondents with information collected through the CAPI method were included (this note applies to all tables and graphics regarding population surveys for the Netherlands 2001 and 2005). 

 This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.  

 For methods and definitions see General population surveys of drug use – methods and definitions

 For survey methods see Table GPS-1 part (ii).  

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 See Table GPS-0.  

(see the help page for information about formats etc.)

Page last updated: Tuesday, 26 January 2010